COMMUNIQUÉS West-GlobeNewswire

AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
28/07/2026
Commercial long-term deal with a large pharmaceutical company pursuing manufacturing and commercial regulatory approvals in major markets Customer commits to AGC Biologics’ new site in Yokohama for five commercial [...]
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
28/07/2026
A featured menopause telehealth option is now available to women exploring DARE to PLAY™, advancing Daré’s strategy to build a trusted women’s health ecosystem spanning products, education and access to care [...]
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
28/07/2026
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care delivery MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
28/07/2026
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook [...]
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
28/07/2026
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
28/07/2026
Brings nearly three decades of leadership spanning NMIBC, corporate strategy and business development to help advance NDV-01 and support the Company's long-term growth and value creation. CORAL GABLES, Fla., July 28, [...]
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
28/07/2026
BOSTON, July 28, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
28/07/2026
Validates OneMedNet’s Position as Premier Supplier of High-Quality Healthcare Data for Advanced AI Training. MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company [...]
Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship
28/07/2026
The expansion marks Dentsply Sirona's sixth dealer network enhancement announced in 2026, further advancing its strategy to broaden access to digital dentistry solutions through trusted distribution partners CHARLOTTE, [...]
Cato Healthcare Supply Strengthens Executive Leadership Team
28/07/2026
DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- Cato Healthcare Supply, the healthcare industry's leading revenue preservation and off-contract procurement platform, today announced the promotion and appointment of four [...]
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
28/07/2026
Delivery of the Bundibugyo viral antigens to Fondazione Biotecnopolo di Siena (“FBS”) and Scripps Research demonstrates C1's potential to accelerate vaccine and monoclonal antibody development, expand platform adoption [...]
Grief goes global on screen as first-of-its-kind festival receives over 500 films from six continents
28/07/2026
Filmmakers across more than 50 countries submitted work on loss and healing, signaling cinema's growing power as a shared language for grief. New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- Grief Fest™ , the first [...]
NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026
28/07/2026
CARMEL, Ind., July 28, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder
28/07/2026
Pemvidutide 2.4 mg delivered a statistically significant and clinically meaningful reduction in heavy drinking days, the primary endpoint of the trial Important secondary endpoints were also met, including two-level [...]
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
28/07/2026
LONDON and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
28/07/2026
No ARIA-E observed across all genotypes, including APOE4 homozygotes ARIA-H tracking background rates Early biomarker movement consistent with target engagement 12-month topline results expected in Q1 2027 Cambridge, [...]
Starget Pharma Expands Scientific Advisory Board with Appointment of Two Global Leaders in Radiopharmaceutical Therapy
28/07/2026
Dr. Oliver Sartor brings more than 35 years advancing the clinical development and commercialization of oncology and radiopharmaceuticals Professor Michael Hofman brings more than 20 years pioneering molecular imaging [...]
Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK
28/07/2026
UK regulatory registration supports commercial launch of regenerative aesthetics portfolio in a marke t with an estimated size of ~$900 million annual ly , an d strengthens the foundation for broader international [...]
Enlivex Announces $400,000,000 Private Placement
28/07/2026
Nes-Ziona, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or “the Company”), a quality longevity company powered by a prediction markets treasury, today announced that it has entered [...]

Pages